| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Glucotrack, Inc. | Director | Common Stock, par value $0.001 per share | 4.06K | $19.8K | $4.87 | Oct 3, 2025 | Direct |
| Glucotrack, Inc. | Director | Series A Common Warrant | 6.89K | Nov 14, 2024 | Direct | ||
| Glucotrack, Inc. | Director | Stock option (right to buy) | 4.06K | Oct 3, 2025 | Direct | ||
| Glucotrack, Inc. | Director | Convertible Promissory Note | 0 | Nov 14, 2024 | Direct | ||
| Glucotrack, Inc. | Director | Series B Common Warrant | 0 | Mar 12, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GCTK | Glucotrack, Inc. | Mar 25, 2025 | 4 | $0 | 4 | Oct 7, 2025 | Director |
| GCTK | Glucotrack, Inc. | Sep 30, 2021 | 17 | $200K | 4 | Mar 31, 2025 | Director |
| GCTK | Glucotrack, Inc. | Jun 22, 2021 | 0 | $0 | 3 | Mar 28, 2025 | Director |